| アブストラクト | INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have attracted much attention because of their significant hypoglycemic and weight-loss effects. Previous preparations can only be subcutaneously injected. Oral administration of GLP-1RAs semaglutide helps to broaden treatment options, but its safety in the real world still needs to be observed. This study is based on FDA adverse event reporting system (FAERS) database to mine adverse drug events (ADE) of oral semaglutide, and provide references for the clinical safe use of this drug. METHODS: To analyze the signal quality of oral semaglutide, which is a drug used in the FAERS database from the third quarter of 2019 to the third quarter of 2023, we collected ADE data and performed data mining by using disproportionate analysis. Then, we standardized the data and used a variety of signal-quantification techniques, including reported odds ratio (ROR), proportional reporting ratio (PRR), Bayesian belief propagation neural network (BCPNN), and multiple empirical Bayesian gamma Poisson contractions (MGPS), for further analysis. RESULTS: We screened 2398 reports on the use of semaglutide tablets, involving a total of 5653 ADE. These reports were mainly submitted by consumers, and the reporting country was mainly the United States. A total of 23 system organ classes (SOC) and 93 preferred terms (PT) were mined for the signals of semaglutide tablets. The three most common SOC were gastrointestinal disorders, general disorders and administration site conditions, and investigations. At the PT level, metabolism and nutrition disorders exhibit the highest number of signals, with the top three being thyroid cyst, acute cholecystitis, and ketosis. Gastrointestinal disorders rank second, primarily involving eructation, pancreatitis, impaired gastric emptying, and regurgitation. In addition, vith nerve paralysis occurs and the signal intensity is high. CONCLUSIONS: Our study provides a deeper and broader understanding of the safety of oral semaglutide. The results of the ROR, PRR, BCPNN, and MGPS algorithms exhibit high consistency, with metabolism and nutrition-related disorders having the highest number of signals. The conclusions align with the technical specifications of the product. Notably, other unexpected effects are reported, including acute cholecystitis, paralysis of the abducens nerve, and positional vertigo. |
|---|
| ジャーナル名 | Diabetes therapy : research, treatment and education of diabetes and related disorders |
|---|
| Pubmed追加日 | 2024/5/22 |
|---|
| 投稿者 | Xiong, Si; Gou, Ruoyu; Liang, Xudong; Wu, Hao; Qin, Shuitao; Li, Bing; Luo, Changjun; Chen, Junan |
|---|
| 組織名 | Department of Ultrasonography, Affiliated Liutie Central Hospital of Guangxi;Medical University, Feie Road Limin District 14, Liuzhou, 545007, Guangxi, China.;School of Public Health, Ningxia Medical University, Shengli Road 1160, Yinchuan,;750003, Ningxia, China.;Department of Cardiology, Affiliated Liutie Central Hospital of Guangxi Medical;University, Feie Road Limin District 14, Liuzhou, 545007, Guangxi, China.;luochangjun@gxmu.edu.cn.;Department of Endocrinology, Affiliated Liutie Central Hospital of Guangxi;261782062@qq.com. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38776037/ |
|---|
